KSK Diagnostics
Hamburg
About KSK Diagnostics
KSK Diagnostics GmbH was established in 2014 and is the first commercial developer of molecular point-of-care diagnostic assays in Hamburg. Our company is focusing on development of Point-of-Care-Tests for molecular diagnostic of infectious diseases and cancer based on our newly developed isothermal amplification technology. Furthermore, we offer highly customizable services of Nucleic Acid-based Test developments based on real-time PCR or RT-PCR, Verification & Validation studies, and product enhancement services for other companies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2017)
- Website: ksk-diagnostics.com
- Phone: +494063674720
Industries & Categories
Biotechnology, Health Diagnostics, Life Science
Canonical: https://fsome.com/organization/ksk-diagnostics-3522810 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.